Detail akcie Rockwell Medical Rg online

Business Summary: Rockwell Medical, Inc. is a healthcare company. The Company develops, manufactures, commercializes, and distributes a portfolio of hemodialysis products for dialysis providers worldwide. The Company operates in the hemodialysis market, which involves the manufacture, sale and distribution of hemodialysis products to hemodialysis clinics, including pharmaceuticals, dialysis concentrates, dialysis kits and other ancillary products used in the dialysis process. Its hemodialysis concentrates products are used to sustain a patient's life by removing toxins and balancing electrolytes in a dialysis patient’s bloodstream. The Company is the supplier of liquid and dry, acid and bicarbonate concentrates for dialysis patients in the United States. The Company manufactures hemodialysis concentrates at its facilities in Michigan, South Carolina, and Texas, and the Company manufactures its dry acid concentrate mixers at its facility in Iowa.
Financial Summary: BRIEF: For the nine months ended 30 September 2025, Rockwell Medical Inc revenues decreased 34% to $50.9M. Net loss applicable to common stockholders totaled $4.8M vs. income of $43K. Revenues reflect hemodialysis market segment decrease of less than 1% to $50.9M, United States segment decrease of 37% to $44.4M. Net loss reflects hemodialysis market segment loss totaling $4.3M vs. income of $612K.